Kriya Therapeutics: Gene Therapy. Redefined.
Kriya is targeting diseases that impact millions of people worldwide and represent areas of high unmet need. We target validated biological pathways with innovative gene therapy approaches that have …
Careers: Future of Gene Therapy - Kriya Therapeutics
Careers Kriya is Changing the Future of Gene Therapy We have an ambitious set of goals, but our confidence – and our inspiration – stems from our people. From California to North Carolina, our …
Metabolic Disease: Gene Therapy for Diabetes and NASH - Kriya …
Kriya is developing KRIYA 839, a potential one-time gene therapy for type 1 diabetes expressing insulin and glucokinase, designed to be delivered intramuscularly with the objective of driving durable …
Neurology: Gene Therapy for Trigeminal Neuralgia - Kriya Therapeutics
Kriya is developing KRIYA‑748, a potential one-time gene therapy for trigeminal neuralgia that expresses a chemogenetically-gated ion channel and is designed to be administered as an injection …
Newsroom: Gene Therapy Pipeline News - Kriya Therapeutics
Sep 12, 2024 · Kriya shares the latest news on our pipeline of life-changing gene therapies to address common diseases.
Kriya Presents Data at the 2025 Association for Research in Vision and ...
Kriya is developing KRIYA-825, a potential one-time gene therapy for Geographic Atrophy (GA) that expresses a fusion protein designed to inhibit the activity of complement C3 and C5, with the …
Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene ...
Sep 12, 2024 · KRIYA-586 is an investigational adeno-associated virus (AAV) gene therapy product engineered to express an antibody that inhibits Insulin-Like Growth Factor 1 Receptor (IGF1R), a key …
Kriya Announces Thirteen Presentations at the American Society of …
Apr 29, 2025 · Kriya is a biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world. With operations in Research Triangle Park, …
Genetic Medicines Science and Product Engine | Kriya Therapeutics
Kriya’s Manufacturing, Product Design, and Research & Development (R&D) capabilities are closely integrated into a unified gene therapy product engine, empowering us to create transformational …
Opthalmology: Gene Therapy for Geographic Atrophy - Kriya …
Kriya is developing KRIYA-825, a potential one-time gene therapy for Geographic Atrophy that expresses a fusion protein designed to inhibit the activity of complement C3 and C5, with the …